AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014 Provided on an Intermittent Schedule for Neurofibromatosis 2 Patients With Progressive or Symptomatic Meningiomas A Single Arm Phase 2 Study of the Dual mTORC1/mTORC2 Inhibitor AZD2014Provided on an Intermittent Sc ...